Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Thalassemia 1Primary Myelofibrosis 1Polycythemia Vera 1Leukemia, Myeloid, Acute 1Graft vs Host Disease 1Bronchiolitis Obliterans Syndrome 1

Interventions

Cyclophosphamide 16Mycophenolic Acid 13Tacrolimus 10fludarabine 9ruxolitinib 8Busulfan 7fludarabine phosphate 6Whole-Body Irradiation 6Sirolimus 6Melphalan 6Methotrexate 5Thiotepa 4ibrutinib 3Specimen Handling 3Cyclosporine 3Abatacept 3Stem Cell Transplantation 2Radiotherapy 2Hematopoietic Stem Cell Transplantation 2Clofarabine 2Biopsy 2vedolizumab 1tildrakizumab 1itacitinib 1blinatumomab 1belumosudil 1axatilimab 1Vorinostat 1Therapeutics 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Panobinostat × 1 year × Clear all
NCT02386800 2026-05-27

CINC424A2X01B Rollover Protocol

Novartis

Phase 4 Active not recruiting
279 enrolled
MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Polycythemia Vera, Thalassemia, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡